en · de · es · fr · pt
lab-handbook.peptides3081.com › Faq › Peptide Identity And Research Origin — Beginner to Advanced

Peptide Identity And Research Origin — Beginner to Advanced

By Editorial Desk · published 2025-09-14 · last reviewed 2025-10-28 · Faq

epitalon comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2025-10-28. Numbers and descriptions here follow the published literature rather than marketing material.

Peptide Identity and Research Origin

Epitalon is a synthetic tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. Its design traces to epithalamin, a peptide fraction prepared from bovine pineal gland extracts that researchers in Saint Petersburg began investigating in the 1970s. The compound has a molecular formula of C14H22N4O9 and a nominal molecular mass near 390 daltons. It holds no approved drug status in the United States or the European Union, and material sold under this name is generally offered as a research chemical rather than a finished pharmaceutical product.

Proposed mechanisms centre on cell-culture observations rather than a defined receptor interaction. Several reports describe increased expression of the telomerase catalytic subunit after exposure of cultured human cells, and the authors attributed the effect to short peptide fragments entering the nucleus and influencing gene transcription. No receptor for the tetrapeptide has been identified, and the free peptide is expected to be degraded rapidly by plasma peptidases. Whether any measurable fraction reaches intact tissues after administration remains an unresolved question rather than an established finding.

Handling, Storage and Analytical Checks

Solubility is high in water, phosphate-buffered saline and normal saline, a pattern that follows from the two acidic residues in the chain. The peptide dissolves poorly in non-polar solvents such as hexane or chloroform. Stock solutions are often prepared in water first and then diluted into the buffer of interest. Because the molecule is small and hydrophilic, filtration through a low-protein-binding membrane is usually straightforward, and visible particulates are uncommon in freshly made solutions.

Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. The chromatogram shows the main peak and any truncated or oxidised by-products, while the mass spectrum confirms the expected 390 dalton mass. Amino acid analysis can corroborate composition when a sample's origin is uncertain. Counterion content, particularly residual trifluoroacetate from purification, is frequently reported alongside purity because it shifts the net mass of the solid.

Reference material is normally supplied as a lyophilised powder in a sealed vial. Product literature typically recommends storage at minus twenty degrees Celsius or colder, protected from light and moisture. Freeze-thaw cycling is usually avoided because repeated condensation can introduce water into the vial. Working solutions are commonly prepared fresh, aliquoted, and kept cold for short periods rather than stored at ambient temperature. Labelling the date of opening helps track how long a vial has been in use.

Epitalon at a glance

PropertyValueNotes
Molecular formulaC14H22N4O9Synthetic tetrapeptide, four residues
Nominal massApproximately 390 DaFree peptide; salt forms differ
AppearanceWhite to off-white powderCommonly supplied lyophilised
Solubility classFreely soluble in waterAlso dissolves in aqueous buffer
Typical storage−20 °C, desiccatedCold packs used during transport

Identity and Research Background

Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.

Epitalon is a synthetic tetrapeptide whose sequence is alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. It was developed in Russia during the 1980s and 1990s by investigators associated with the St. Petersburg Institute of Bioregulation and Gerontology, who studied short peptides as regulators of gene expression and tissue function. The alternative spelling epithalon appears interchangeably in the literature, and the two names refer to the same molecule. Outside Russia it is encountered chiefly as a research chemical rather than a licensed medicine, and it holds no approval from the United States Food and Drug Administration or the European Medicines Agency.

The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.

Related pages on this site

Epitalon in Research Literature and Handling

Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.

Analytical characterization of epitalon relies on standard peptide methods. Reverse-phase high-performance liquid chromatography is used to assess purity, and mass spectrometry confirms identity by checking the observed mass against the expected value near 390 daltons. Amino acid analysis can verify composition. Because the peptide is short and hydrophilic, it elutes early on many reverse-phase columns, so method development often requires ion-pairing reagents to achieve adequate retention and resolution from related impurities.

Epitalon Background and Discovery

The peptide emerged from research carried out in Saint Petersburg from the late 1980s onward, where investigators searched for shorter active fragments of a pineal preparation known as epithalamin. The name epitalon was chosen to reflect that parent extract. Early reports described effects on neuroendocrine markers and on the lifespan of laboratory animals. Much of that work appeared in Russian-language journals, with English translations following later, which affects how readily the original protocols can be assessed by outside groups.

Published studies on epitalon are dominated by a small number of research groups, and independent replication in other laboratories remains limited. Proposed mechanisms include activation of telomerase and modulation of melatonin rhythms, but the evidence for either rests mainly on cell cultures and animal models. Whether the peptide produces comparable effects in humans is an open question, and the absence of large controlled trials means the literature is best read as exploratory rather than settled.

Epitalon is a synthetic four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9, and its calculated molar mass is approximately 390.35 grams per mole. The compound is a short fragment related to a peptide fraction isolated from bovine pineal gland extracts, and it is normally supplied as a lyophilised powder intended for laboratory research. It is not a registered pharmaceutical product in most countries.

Analytical Methods And Handling

Purity assessment of peptide reagents normally relies on reversed-phase high-performance liquid chromatography. A gradient of acetonitrile in water with trifluoroacetic acid, paired with a C18 stationary phase, separates the target tetrapeptide from truncated sequences and deletion analogues. Detection at 214 nanometres exploits absorbance of the peptide backbone, since the molecule contains no aromatic residue. Results are expressed as a percentage of total peak area. Values above ninety-five percent are typical for research-grade material, although reporting conventions vary between suppliers.

Identity confirmation uses mass spectrometry, usually electrospray ionisation in positive mode or matrix-assisted laser desorption. The protonated free peptide produces a signal near three hundred and ninety-one daltons, while salt adducts shift that value slightly. Tandem mass spectrometry or amino acid analysis supplies sequence-level confirmation, which a single mass measurement cannot. Peptides containing aspartate can cyclise into succinimide intermediates that hydrolyse to isoaspartate isomers of identical mass. Because those isomers are difficult to separate chromatographically, identity and purity results carry more weight when interpreted together.

Notes from published material

=== Surgical anatomy for nasal reconstruction === The human nose is a sensory organ that is structurally composed of three types of tissue: (i) an osseo-cartilaginous support framework (nasal skeleton), (ii) a mucous membrane lining, and (iii) an external skin. The anatomic topography of the human nose is a graceful blend of convexities, curves, and depressions, the contours of which show the underlying shape of the nasal skeleton. Hence, these anatomic characteristics permit dividing the nose into nasal subunits: (i) the midline (ii) the nose-tip, (iii) the dorsum, (iv) the soft triangles, (v) the alar lobules, and (vi) the lateral walls. Surgically, the borders of the nasal subunits are ideal locations for the scars, whereby is produced a superior aesthetic outcome, a corrected nose with corresponding skin colors and skin textures.

nebeprisikiškiakopūstlapiaujančiuosiuose – "in those, of masculine gender, who aren't gathering enough wood sorrel's leaves by themselves anymore." – the plural locative case of past iterative active participle of verb kiškiakopūstlapiauti meaning "to pick wood-sorrels' leaves" (leaves of edible forest plant with sour taste, word by word translation "rabbit cabbage"). The word is attributed to software developer / writer Andrius Stašauskas.

==== United States ==== Luvesilocin is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

== Research == Bunch was a postdoctoral researcher at the University of Sheffield, where she was awarded an Enterprise Fellowship to commercialise imaging using mass spectrometry. She joined the University of Birmingham, leading a large multi-disciplinary group using MALDI Mass spectrometry. She remains an honorary senior research fellow at the University of Birmingham. She also holds a chair in Biomolecular Mass Spectrometry at Imperial College London. She joined the National Physical Laboratory in 2013, where she became responsible for research in MALDI metrology. In 2017 Bunch was funded by Cancer Research UK's Grand Challenge to map tumours at a molecular and cellular level. She came up with the idea when listening to a BBC Radio 4 program about the Cancer Research UK Grand Challenges. The investment was worth £16 million, and uses mass spectrometry imaging techniques to study breast, bowel and pancreatic tumours in "unprecedented detail. She spoke about the project at the Hay Festival and presented their project at the Royal Society Summer Exhibition. She is part of a COST (European Cooperation in Science and Technology) Action on mass spectrometry imaging.

Sources: en.wikipedia.org

Background from the literature

=== Overview of European experience in nuclear partitioning === A lot of research funded by the European Commission is being devoted to hydrometallurgical processes for the partitioning and transmutation of trivalent actinides (An). These research programs have first led to multicycle processes, secondly to the development of simplified and innovative processes. The hydrometallurgical partitioning consists of two relevant steps: extraction and stripping. In the first step the organic phase, containing the extracting ligand dissolved in a suitable solvent, is contacted with the aqueous phase coming from the dissolution of the irradiated fuel. The solutes present in the aqueous phase are extracted by a complexation reaction with the extracting agent and transferred into the organic phase in which the formed complexes are soluble. The second step, known as stripping, is obtained by reversing the complexation reaction, where the solutes are back-extracted into another aqueous solution usually different in acidity compared to the previous one. The main goal is to develop reliable and affordable industrial separation processes by lipophilic and hydrophilic ligands to selectively extract minor actinides from the (3–4) M acidic target waste downstream of the PUREX process, but with the more challenging goal to minimize the amount of solid secondary waste.

=== Energy === In July 2018, Minister Rickford tabled Bill 2: Urgent Priorities Act, which received Royal Assent in the same month. The first session of the 42nd Legislature was on July 11 and Bill 2, which passed into law on July 25, was the Ford Government's first piece of legislation. Bill 2—an omnibus bill—was "criticized by both "business groups and unions". It legislated an end to the strike between York University and Canadian Union of Public Employees (CUPE), cancelled the White Pines Wind Project wind farm contract, and gave Ontario government "veto power over compensation at Hydro One." In December 2025, Ford and New York governor Kathy Hochul signed a memorandum of understanding which makes the New York Power Authority and Ontario Power Generation work together on advancing nuclear energy technology. In July 2026, Ford and Alberta premier Danielle Smith proposed an oil pipeline from Alberta to Sarnia, Ontario.

==== Clinical Cancer Center ==== Clinical Cancer Centers generally conduct a combination of basic, population sciences and clinical research, and are encouraged to stimulate collaborative research involving more than one field of study. Clinical cancer centers may apply for up to $1.4 million per year.

Continuous ion sources (most commonly electrospray ionization, ESI) are generally interfaced to the TOF mass analyzer by "orthogonal extraction" in which ions introduced into the TOF mass analyzer are accelerated along the axis perpendicular to their initial direction of motion. Orthogonal acceleration combined with collisional ion cooling allows separating the ion production in the ion source and mass analysis. In this technique, very high resolution can be achieved for ions produced in MALDI or ESI sources. Before entering the orthogonal acceleration region or the pulser, the ions produced in continuous (ESI) or pulsed (MALDI) sources are focused (cooled) into a beam of 1–2 mm diameter by collisions with a residual gas in RF multipole guides. A system of electrostatic lenses mounted in high-vacuum region before the pulser makes the beam parallel to minimize its divergence in the direction of acceleration. The combination of ion collisional cooling and orthogonal acceleration TOF has provided significant increase in resolution of modern TOF MS from few hundred to several tens of thousand without compromising the sensitivity.

The introduction of Freon in the 1920s expanded the refrigerator market during the 1930s. Home freezers as separate compartments (larger than necessary just for ice cubes) were introduced in 1940. Frozen foods, previously a luxury item, became commonplace. Freezer units are used in households as well as in industry and commerce. Commercial refrigerator and freezer units were in use for almost 40 years prior to the common home models. The freezer-over-refrigerator style had been the basic style since the 1940s, until modern, side-by-side refrigerators broke the trend. A vapor compression cycle is used in most household refrigerators, refrigerator–freezers and freezers. Newer refrigerators may include automatic defrosting, chilled water, and ice from a dispenser in the door. Domestic refrigerators and freezers for food storage are made in a range of sizes. Among the smallest are Peltier-type refrigerators designed to chill beverages. A large domestic refrigerator stands as tall as a person and may be about one metre (3 ft 3 in) wide with a capacity of 0.6 m3 (21 cu ft). Refrigerators and freezers may be free standing, or built into a kitchen. The refrigerator allows the modern household to keep food fresh for longer than before. Freezers allow people to buy perishable food in bulk and eat it at leisure, and make bulk purchases.

Sources: en.wikipedia.org

Frequently asked questions

Is epitalon the same as epithalamin?

No. Epithalamin is a heterogeneous peptide fraction obtained from pineal gland extract and contains many components. Epitalon is a single synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. Researchers synthesised the shorter peptide while attempting to identify active sequences within the extract.

Does epitalon occur naturally in the human body?

No endogenous peptide with this exact sequence has been described as a circulating hormone or signalling molecule. The tetrapeptide was designed as a synthetic analogue based on fragments observed in pineal preparations. Any activity discussed in the literature therefore refers to administered material rather than to a natural pool of the compound.

What regulatory category does epitalon fall into?

It is not an approved medicine in major jurisdictions and does not appear in the major pharmacopoeias. Material is usually distributed as a research chemical or laboratory reagent. Such labelling places handling responsibility on the purchaser and does not indicate that a regulatory body has reviewed the substance.

How should epitalon powder be stored?

Sealed lyophilised powder is normally kept at minus twenty degrees Celsius or below, away from light and moisture. Vials are allowed to reach room temperature before opening to limit condensation. Repeated warming and cooling of the same vial is discouraged.

Network